TLC Vision Corp. To Present At Scotia Capital’s Pharmaceutical And Biotechnology Conference

TLC Vision Corporation (TSX:TLC)(NASDAQ: TLCV), North America’s premier eye care services company, announced today that Jim Wachtman, President & CEO and Steve Rasche, VP Finance & CFO, will present at the Scotia Capital Pharmaceutical and Biotechnology Conference in Toronto, Canada on Wednesday, April 26th at 9:00am Eastern Time. The conference will be held at Le Royal Meridien King Edward Hotel in Toronto at 37 King Street East. The presentation will review the company’s performance and refractive growth strategy.

MORE ON THIS TOPIC